A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria

The cause of premenstrual dysphoric disorder (PMDD) is largely unknown. It has been hypothesized that normal ovarian function triggers PMDD-related biochemical events within the brain and that serotonin plays an important role. In the present study, positron emission tomography (PET) and [carbonyl-(11)C]WAY-100635 were used to examine serotonin 5-HT(1A) receptors in a control group of women and in a group of women with PMDD. Two PET examinations were performed in each subject, one before (follicular phase) and one after ovulation (luteal phase). Each subject's menstrual cycle was confirmed by ultrasonography of the ovaries as well as with hormone levels in blood and urine. The 5-HT(1A) binding potential was measured in six regions of interest and calculated according to the simplified reference tissue model. In the raphe nuclei, the 5-HT(1A) binding potential changed from the follicular to the luteal phase of the menstrual cycle in asymptomatic controls. In women with PMDD, the observed change between phases was significantly smaller. The results are in concordance with previously reported challenge studies of 5-HT(1A) receptor-mediated effects indicating different serotonergic responses between women with PMDD and controls. The study principally provides new support, in vivo, for a serotonergic dysregulation in women with PMDD.

[1]  H. Wikström,et al.  Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635 , 1997, Brain Research.

[2]  W. Crowley,et al.  Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. , 1986, The Journal of clinical endocrinology and metabolism.

[3]  K. Merikangas,et al.  The epidemiology of perimenstrual psychological symptoms , 2001, Acta psychiatrica Scandinavica.

[4]  J. Bancroft,et al.  Mood, Sexuality, Hormones, and the Menstrual Cycle. II. Hormone Levels and Their Relationship to the Premenstrual Syndrome , 1983, Psychosomatic medicine.

[5]  J. Endicott,et al.  Psychiatric evaluation of premenstrual changes. , 1985, Psychosomatics.

[6]  Roger N. Gunn,et al.  Tracer Kinetic Modeling of the 5-HT1AReceptor Ligand [carbonyl-11C]WAY-100635 for PET , 1998, NeuroImage.

[7]  Faith M. Gunning-Dixon,et al.  Sex differences in temporo-limbic and frontal brain volumes of healthy adults. , 2002, Cerebral cortex.

[8]  J. Veldhuis,et al.  Pulsatile cosecretion of estradiol and progesterone by the midluteal phase corpus luteum: temporal link to luteinizing hormone pulses. , 1990, The Journal of clinical endocrinology and metabolism.

[9]  L. Uphouse,et al.  Estrous cycle modulation of extracellular serotonin in mediobasal hypothalamus: role of the serotonin transporter and terminal autoreceptors , 1999, Brain Research.

[10]  S. Tonge,et al.  Proceedings: Variations in the concentrations of monamines and their metabolites in eight regions of rat brain during the oestrous cycle: a basis for interactions between hormones and psychotropic drugs. , 1975, The Journal of pharmacy and pharmacology.

[11]  K. Zilles,et al.  Brain atlases - a new research tool , 1994, Trends in Neurosciences.

[12]  A. Biegon,et al.  Serotonin receptor concentration during the estrous cycle of the rat , 1980, Brain Research.

[13]  Victoria Arango,et al.  Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635 , 2002, Brain Research.

[14]  C. Gundlah,et al.  Differences in hypothalamic serotonin between estrous phases and gender: an in vivo microdialysis study , 1998, Brain Research.

[15]  C. Halldin,et al.  Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  Chester A. Mathis,et al.  Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study , 2000, Biological Psychiatry.

[17]  E. Coccaro,et al.  Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans. , 1990, Psychopharmacology bulletin.

[18]  D. Rubinow,et al.  Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. , 1988, American journal of obstetrics and gynecology.

[19]  T. Greitz,et al.  Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. , 1981, Journal of computer assisted tomography.

[20]  J. Endicott,et al.  Premenstrual depression predicts future major depressive disorder , 1990, Acta psychiatrica Scandinavica.

[21]  C. Ashby,et al.  Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome , 2005, Journal of Neural Transmission / General Section JNT.

[22]  E. Eriksson,et al.  The Serotonin Reuptake Inhibitor Paroxetin Is Superior to the Noradrenaline Reuptake Inhibitor Maprotiline in the Treatment of Premenstrual Syndrome , 1995, Neuropsychopharmacology.

[23]  Peter W. Jones,et al.  Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review , 2000, The Lancet.

[24]  David A Lewis,et al.  Neural and behavioral substrates of mood and mood regulation , 2002, Biological Psychiatry.

[25]  G. Rajkowska,et al.  Increase in Serotonin-1A Autoreceptors in the Midbrain of Suicide Victims with Major Depression—Postmortem Evidence for Decreased Serotonin Activity , 1998, The Journal of Neuroscience.

[26]  D. Rubinow,et al.  Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. , 1998, The New England journal of medicine.

[27]  E. Coccaro,et al.  Physiological responses to d-fenfluramine and ipsapirone challenge correlate with indices of aggression in males with personality disorder. , 1995, International clinical psychopharmacology.

[28]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[29]  L. Yatham.  Is 5HT1A Receptor Subsensitivity a Trait Marker for Late Luteal Phase Dysphoric Disorder? A Pilot Study * , 1993, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[30]  K Wienhard,et al.  The ECAT EXACT HR: Performance of a New High Resolution Positron Scanner , 1994, Journal of computer assisted tomography.

[31]  G. Goodwin,et al.  Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change , 1991, Psychological Medicine.

[32]  M Slifstein,et al.  Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input Functions , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  P. Slater,et al.  Abnormal persistence of cerebellar serotonin-1A receptors in schizophrenia suggests failure to regress in neonates , 1998, Journal of Neural Transmission.

[34]  M. Landén,et al.  How does premenstrual dysphoric disorder relate to depression and anxiety disorders? , 2003, Depression and anxiety.

[35]  A. Rapkin,et al.  Platelet monoamine oxidase B activity in women with premenstrual syndrome. , 1988, American journal of obstetrics and gynecology.

[36]  T. Grady-Weliky.  Premenstrual dysphoric disorder , 2003 .

[37]  B. Bogerts,et al.  Circumscribed numerical deficit of dorsal raphe neurons in mood disorders , 2002, Psychological Medicine.

[38]  E. Frank,et al.  Symptomatic Improvement of Premenstrual Dysphoric Disorder With Sertraline Treatment: A Randomized Controlled Trial , 1997 .

[39]  Flügge,et al.  5HT1A‐Receptor Binding in the Brain of Cyclic and Ovariectomized Female Rats , 1999, Journal of neuroendocrinology.

[40]  P. Cowen,et al.  Pindolol decreases prolactin and growth hormone responses to intravenousL-tryptophan , 2005, Psychopharmacology.

[41]  C. Nemeroff,et al.  Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome. , 1992, American journal of obstetrics and gynecology.

[42]  D. Kupfer,et al.  Pet imaging of serotonin 1A receptor binding in depression , 1999, Biological Psychiatry.

[43]  A. Bond,et al.  Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression , 2000, Psychopharmacology.

[44]  Chester A. Mathis,et al.  Gender-specific aging effects on the serotonin 1A receptor , 2001, Brain Research.

[45]  J. Endicott,et al.  Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. , 1997, The American journal of psychiatry.

[46]  U. Halbreich.  Premenstrual dysphoric disorders, anxiety, and depressions: vulnerability traits or comorbidity. , 1995, Archives of general psychiatry.

[47]  P A Sargent,et al.  Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. , 2000, Archives of general psychiatry.

[48]  Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. , 1984 .

[49]  E. Frank,et al.  Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group. , 1997, JAMA.

[50]  J. Endicott,et al.  Relationship of dysphoric premenstrual changes to depressive disorders , 1985, Acta psychiatrica Scandinavica.